Angleški jezik Naslov: The efficacy and safety of ramipril as monotherapy and in fixed-dose combination with kardio hipertenzija hipertenzija in the treatment of different groups of hypertensive patients and its effect on cardiovascular prevention Izvleček: Hypertension is a major health problem in the world.
One kardio hipertenzija every three adultshas high blood pressure BP.
The excessive pressure on the artery wallscaused by high BP kardio hipertenzija damage blood vessels, as well as organs in the body. Uncontrolled high BP can lead to different complications. Hypertension is accompanied by cardiovascular risk factors, such kardio hipertenzija diabetes, previous myocardial infarction or stroke, dyslipidemia, obesity or proven vascular disease, in at least twothirds of all cases. Todayʼs treatment of hypertensionis very challenging, especially in patients with enhanced cardiovascular risk, where a multiple pharmacological approach is often required to achieve an acceptable BP goal.
Ramipril is a lipophilic ACE inhibitor suitable for once-daily administration. It effectively reduces peripheral vascular resistance, thus regulating high BP. In combination with hydrochlorothiazide, it produces a synergetic effect, which increases the efficacy and safety of both drugs.
Ramipril has been studied in numerous clinical studies. Also the efficacy and safety of Krkaʼs ramipril AmprilŽ kardio hipertenzija been studied in several clinical and post-authorisation safety and efficacy upotreba pentoksifilin hipertenzije. Krkaʼs ramipril is offered in a variety of dosage forms, kardio hipertenzija and fixed-dose combinations.
Podobna dela Podobna dela v drugih slovenskih zbirkah: Komentarji Za komentiranje se morate prijaviti.